Early experience of a multicentre phase I/II study of hypofractionated radiotherapy (55Gy/16 fractions/4 weeks) for localized prostate cancer

被引：0
|
作者：
Wu, J.
Skarsgard, D.
Pearcey, R.
Cadman, P.
Murray, B.
Newcomb, C.
机构：
[1] Tom Baker Canc Clin, Radiat Therapy Program, Calgary, AB, Canada
[2] Saskatoon Canc Ctr, Saskatoon, SK, Canada
[3] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：244 / 244
页数：1
相关论文
共 50 条
  • [21] ACCELERATED HYPOFRACTIONATED RADIOTHERAPY (RT) FOR NON-SMALL CELL LUNG CANCER (NSCLC): A SINGLE CENTRE AUDIT OF OUTCOME USING 55GY IN 20 DAILY FRACTIONS.
    Garikipati, Satya
    Srinivasan, Dev
    Hatton, Nathaniel L.
    Lee, Caroline
    Fisher, Patricia M.
    Mohanamurali, Jayaram
    Hatton, Matthew
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S813 - S814
  • [22] Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a phase I/II feasibility study
    Sara Junius
    Karin Haustermans
    Barbara Bussels
    Raymond Oyen
    Bianca Vanstraelen
    Tom Depuydt
    Jan Verstraete
    Steven Joniau
    Hendrik Van Poppel
    Radiation Oncology, 2
  • [23] Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a phase I/II feasibility study
    Junius, Sara
    Haustermans, Karin
    Bussels, Barbara
    Oyen, Raymond
    Vanstraelen, Bianca
    Depuydt, Tom
    Verstraete, Jan
    Joniau, Steven
    Van Poppel, Hendrik
    RADIATION ONCOLOGY, 2007, 2 (1)
  • [24] Phase I/II study on stereotactic hypofractionated onceweekly radiation therapy (SHORT) for localized prostate cancer.
    Mallick, Indranil
    Arunsingh, Moses
    Prasath, Sriram
    Arun, B.
    Roy, Paromita
    Dabkara, Deepak
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [25] Hypofractionated image-guided radiotherapy with 70 Gy in 28 fractions for prostate cancer confined to the pelvis: a single institute experience in Taiwan
    Mu, Hui-Lei
    Chi, Mau-Shin
    Ko, Hui-Ling
    Juang, Guang-Dar
    Hwang, Thomas I-Sheng
    Chi, Kwan-Hwa
    Yang, Kai-Lin
    BMC UROLOGY, 2025, 25 (01):
  • [26] SBRT for localized prostate cancer using Tomotherapy: current results of a phase II study (8 fractions in two weeks)
    Macias Hernandez, V.
    Blanco, M.
    Ciprian, D.
    Perez Romasanta, L. A.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S120 - S121
  • [27] Hypofractionated radiotherapy for low-risk prostate cancer: Early report on acute toxicity of a phase I/II trial
    Nguyen, D. H. A.
    Menkarios, C.
    Vigneault, E.
    Brochet, N.
    Bahary, J-P.
    Jolicoeur, M.
    Fortin, M-A.
    Nguyen, T. V.
    Fortin, B.
    Guay, J-P.
    Lambert, C.
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S44 - S45
  • [28] PROSPECTIVE STUDY OF EXTREME HYPOFRACTIONATED RADIOTHERAPY (35 GY IN FIVE FRACTIONS) FOR LOW-RISK PROSTATE CANCER: TOXICITY RESULTS
    Ouon, H.
    Cheung, P.
    Cesta, A.
    Holden, L.
    Tang, C.
    Pang, G.
    Morton, G.
    Basran, P.
    Tirona, R.
    Mamedov, A.
    Deabreu, A.
    Loblaw, A.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S46 - S46
  • [29] , HYPOFRACTIONATED RADIOTHERAPY FOR LOW RISK PROSTATE CANCER: PRELIMINARY RESULTS OF A PHASE I/II TRIAL
    Menkarios, C.
    Nguyen, D. H. A.
    Vigneault, E.
    Brochet, N.
    Bahary, J. P.
    Jolicoeur, M.
    Nguyen, T. Van
    Beauchemin, M. C.
    Fortin, B.
    Fortin, M. A.
    Lambert, C.
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S42 - S42
  • [30] Phase I study on hypofractionated accelerated radiotherapy for bone metastases from prostate cancer
    Torre, G.
    Macchia, G.
    Nuzzo, M.
    Deodato, F.
    Labropoulos, F.
    Picardi, V.
    Cammelli, S.
    Cappuccini, J.
    Guido, A.
    Ntreta, M.
    Siepe, G.
    Arcelli, A.
    Compagnone, G.
    Schiavina, R.
    Martorana, G.
    Morganti, A. G.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S663 - S663
12345